Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design
Year: 2025
Type: article
Study design: Study Protocol
Source: Contemporary Clinical Trials
Authors: Ekaterina V. Kurbatova, Kelly E. Dooley, Wendy Carr, Jason E. Stout, Eric L. Nuermberger, Patrick P.J. Phillips, Nigel A. Scott, Caryn M. Upton, Elisa Ignatius, Michelle Haas, Nicholas D. Walter, Rita M. Traxler, Nicole E. Brown, Rosanna Boyd, Kia E. Bryant, Meredith G. Dixon, Rada Savic, Christie Eichberg, Anneke Hesseling, Charles Bark, Debra A. Benator, Grace Muzanyi, Nicholas S. Twycross, Greg J. Fox, Samuel Pierre, Joseph Burzynski, Daniel W. Fitzgerald
Institutions: Centers for Disease Control and Prevention, Vanderbilt University Medical Center, Duke University, Johns Hopkins University, University of California, San Francisco, Task Applied Science, Brooklyn Chest Hospital, University of Colorado Anschutz, University of Colorado Denver, Medical University of South Carolina, Stellenbosch University, Case Western Reserve University, George Washington University, University of Cape Town, The University of Sydney, Gheskio Centers, New York City Department of Health and Mental Hygiene, Cornell University, Weill Cornell Medicine
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G1242492668, Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor), Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium, G7543494365, Optimizing Anti-mycobacterial Therapy Using A Pharmacology-based Approach, Mentoring Investigators in HIV and Tuberculosis Therapeutics Research
OpenAlex ID: W4414008458